Mariner’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.3M Buy
662,081
+206,494
+45% +$14.4M 0.07% 254
2025
Q1
$33.5M Buy
455,587
+250,017
+122% +$18.4M 0.06% 278
2024
Q4
$13.5M Buy
205,570
+25,998
+14% +$1.7M 0.02% 460
2024
Q3
$14M Buy
179,572
+5,854
+3% +$456K 0.02% 438
2024
Q2
$13.5M Buy
173,718
+58,475
+51% +$4.56M 0.03% 423
2024
Q1
$7.81M Sell
115,243
-27,115
-19% -$1.84M 0.02% 579
2023
Q4
$9.59M Sell
142,358
-2,871
-2% -$193K 0.02% 483
2023
Q3
$9.83M Sell
145,229
-5,668
-4% -$384K 0.03% 439
2023
Q2
$10.8M Buy
150,897
+3,986
+3% +$285K 0.03% 416
2023
Q1
$10.2M Buy
146,911
+33,926
+30% +$2.35M 0.03% 431
2022
Q4
$7.66M Sell
112,985
-5,619
-5% -$381K 0.02% 473
2022
Q3
$6.5M Buy
118,604
+58,459
+97% +$3.21M 0.03% 439
2022
Q2
$3.97M Sell
60,145
-2,487
-4% -$164K 0.02% 543
2022
Q1
$4.16M Buy
62,632
+4,738
+8% +$314K 0.02% 538
2021
Q4
$3.37M Buy
57,894
+11,537
+25% +$672K 0.01% 518
2021
Q3
$2.78M Buy
46,357
+10,255
+28% +$616K 0.01% 464
2021
Q2
$2.16M Buy
36,102
+1,963
+6% +$118K 0.01% 473
2021
Q1
$1.7M Buy
34,139
+4,976
+17% +$247K 0.01% 489
2020
Q4
$1.46M Sell
29,163
-7,412
-20% -$371K 0.01% 491
2020
Q3
$2.01M Sell
36,575
-2,559
-7% -$140K 0.02% 373
2020
Q2
$2.07M Buy
39,134
+10,304
+36% +$545K 0.02% 375
2020
Q1
$1.29M Buy
28,830
+11,432
+66% +$511K 0.02% 432
2019
Q4
$867K Buy
17,398
+354
+2% +$17.6K 0.01% 528
2019
Q3
$760K Sell
17,044
-680
-4% -$30.3K 0.01% 521
2019
Q2
$732K Buy
17,724
+2,912
+20% +$120K 0.01% 603
2019
Q1
$599K Buy
+14,812
New +$599K 0.01% 606
2018
Q3
Sell
-7,096
Closed -$249K 808
2018
Q2
$249K Buy
+7,096
New +$249K 0.01% 683